Abstract
Most of the early medicines relied on the prescription of specific plants and herbs for medications. This practice is still supported by the present-day research, because of the bioactive phytocomponents present in them. Acting as a defense barrier against several plant pathogens, including bacteria, viruses, and fungi, phytochemicals are also associated with the diminution of lethal diseases in humans, such as hypertension, diabetes, heart disease, etc., and can also effectively diminish the risks of developing certain cancers. Cancer is considered as a neoplastic disease, and despite advances in the modern medicine, it is still the fundamental cause of mortalities in developing as well as developed countries. Specifically, phytochemicals may act as antioxidants and/or nutrient protectors and inhibit the formation of carcinogens (cancer-causing agents) in the body. Furthermore, the potential benefits of phytochemicals as an anticancer agent also include improving the immune system, reducing inflammation, preventing DNA damage, and facilitating DNA repair, thereby slowing down cancer cell growth, regulating hormones, and preventing damaged cells from reproducing. The literature supports the fact that phytochemicals are advantageous, because of their safe, low-toxic, universal availability and their ability to synergize with chemotherapy and radiotherapy. Different studies suggest that regular intake of dietary phytochemicals is allied to low cancer risks. Thus, in this chapter, a summary of the therapeutic perspective of natural phytochemicals and cancer chemoprevention has been presented. Further, different mechanisms of cancer prevention using phytochemicals are discussed.
Access provided by Autonomous University of Puebla. Download chapter PDF
Similar content being viewed by others
Keywords
16.1 Introduction to Cancers
16.1.1 Definition and General Types of Cancer
The uncontrollable and abnormal growth of cells by disregarding standard rules of cell division leads to form cancers. Generally, signals for differentiation, division, or death are provided to the cells. But, cancer cells are independently against to these signals, and lead to abandoned growth and proliferation. It can be mortal if proliferation continues and spreads. Various studies articulate that nearly 90% of cancer-allied deaths are attributable to the spread of tumors. Thus, the progression is termed as metastasis (Kumar et al. 2015; Miller et al. 2016). Conferring to different types of cells human body resides, cancer types are distributed into five major categories, i.e., leukemia, carcinoma, lymphoma, myeloma, and sarcoma as well as spinal cord and brain cancers. Their distribution and subtypes are highlighted in Fig. 16.1. The classification chart has been compiled using data available on World Health Organization (WHO), International Classification of Diseases for Oncology (ICD-O) (https://codes.iarc.fr/).
16.1.2 Risk Factors of Cancer
Risk factors of cancer differ from types of cancer as well as the age of cancer patients. According to the National Cancer Database (NCDB) and the American Cancer Society (ACS) (https://www.cancer.org/) database, habitual or lifestyle-related factors, which increases risk of many different types of cancer include smoking, consumption of alcohol, unhealthy food, insufficient exercise, and being overweight. Environmental factors like exposure to different radon, air pollution, and radiations in the course of medical examinations or processes are also accountable in certain adult cancers. However, natural or artificial ultraviolet (UV) is shown to increase risks of skin cancers, including melanoma. These risks usually take several years of impact for cancer risk, so it can be reflected in adult age and not in children or teens, while childhood cancer treated with radiotherapy or chemotherapy can later acquire second cancer, specifically leukemia. Changes in DNA (inherited as well as acquired gene mutations) leads to relax suppressor genes or go for oncogenes that could also trigger cancer, whereas some of the cancers including cervical can be acquired by human papillomavirus (HPV) infections. In addition, risk of Kaposi sarcoma, Hodgkin lymphoma, and a few other cancers can be acquired by human immunodeficiency virus (HIV) infections (https://www.facs.org/quality-programs/cancer/ncdb/about).
16.1.3 Treatments of Cancer
Cancer can be treated by different means unrelated to the stages of cancer and the condition of patients. The traditional therapy includes radiotherapy, chemotherapy, immunotherapy, surgery, as well as targeted therapy (Njuguna et al. 2018). Various new forms of treatments are also considered nowadays which depend on the information about clinical trials. These are deliberated as complementary and alternative therapies comprising photodynamic therapy, stem cell transplant, hyperthermia, donation and transfusion of blood, laser treatment, etc. (Miller et al. 2016; Njuguna et al. 2018).
16.1.4 Side Effects of Anticancer Drugs (Synthetic Drugs)
The most common side effects of anticancer drugs include vomiting, nausea, fatigue, infections (Ayoub et al. 2018), mouth problems, swelling, ostomies, pain, leg cramps (Baden 2015), fever, falling, sleep problems, seizures, eating problems, sweating, weakness, hiccups, changes in thinking or moods, prostheses, low blood counts, peripheral neuropathy, shortness of breath, urine or stool changes, lymphedema, sexual and fertility side effects, emotional side effects (depression, anxiety, distress) (El-Mowafy 2018), skin problems, dehydration (lack of fluids) (Ng et al. 2018), and hair loss (Wallisellen 2019). One of the synthetic anticancer drugs is doxorubicin, which is also effective against acute lymphoblastic leukemia and different breast, ovaries, and hepatocellular carcinomas. It is found that doxorubicin has harmful effects like cardiotoxicity which can lead to heart failure (Chen et al. 2011). Similarly, aspirin and celecoxib used for anticancer treatment caused some side effects like gastrointestinal bleeding, heart attack, and stroke (Cheng et al. 2016), whereas Pan-histone deacetylases (pHDACs) inhibitors used as anticancer agent possess several side effects including taste disturbance, diarrhea, fatigue, weight loss, cardiac arrhythmias, bone marrow depression, and electrolyte changes (Prasad and Katiyar 2015). Few chemotherapy drugs, consisting of antimetabolites like methotrexate, hormones, molecular targeting agents, anti-tubulin agents like taxanes, and some DNA-interactive agents like cisplatin and doxorubicin are used for cancer therapy. However, these drugs are escorted with quite a few undesirable side effects like hair loss, bone marrow suppression, neurological problems, cardiotoxicity, and gastrointestinal injuries (Hosseini and Ghorbani 2015; El-Mowafy 2018; Wallisellen 2019). So researchers are hunting for some innovative anticancer agents from natural resources revealing insignificant side effects and enhanced efficacy.
16.2 Phytochemicals: Introduction and Different Mechanisms of Cancer Prevention by Phytochemicals
Phytochemicals are bioactive non-nutrient composites, originated in plants, and are responsible for the pigments, flavor, as well as fragrance of foods (Thomas et al. 2015). Over and above 5000 phytochemicals have been predicted in fruits, grains, and vegetables, while many of them are still unidentified (Hosseini and Ghorbani 2015). Phytochemicals positively affect human health via various mechanisms like signal transduction modulation, epigenetic modifications, regulating antioxidant properties, and modulation of metabolic pathways. Hence, phytochemicals have comprehensively been studied for their anticancer potential through apoptosis, autophagy, angiogenesis, cellular differentiation, modulation of cancer growth, and its initiation with the aim of reducing side effects like nausea and fatigue (Tabolacci et al. 2019). Many studies have allied that intake of dietary phytochemicals has lowered the incidence of cancer by involving as safeguards in enhancing the repair of DNA, protecting by arming our antioxidant enzymes, and many more (Thomas et al. 2015).
Few plants, as well as phytochemical compounds, responsible for anticancer properties through some of the possible mechanisms are reviewed in this chapter and depicted in Fig. 16.2.
16.2.1 Through Antioxidant Activity
Compounds, inhibiting oxidation reaction that yields free radicals and leads to chain of reactions in order to damage cells are termed as antioxidants. Hence, these antioxidants are essential to maintain integrity of cells as well as homeostasis of the host immune system (Thyagarajan and Sahu 2018). Different antioxidants in foods, including phenols, flavonoids, carotenoids, curcumin, and nobiletin are recognized to be potent for the anti-carcinogenic property. The in vitro studies confirm that supplementing resveratrol- and flavonoid-rich fruits and vegetables in specific proportion lowered the rate of breast, prostate, and renal cancers (Bennett et al. 2012), while the carotenoid mixture helped to suppress hepatoma developed in liver cancer with a high risk as well as help to reduce breast cancer risk. Similarly, nobiletin and curcumin exhibited initiation of antitumor effects (Nishino et al. 2004). In another study, antioxidants like vitamin E and selenium reduced prostate and colon cancer risks. The study revealed that antioxidant vitamins and few phytochemicals help cancer cells to induce apoptosis and prevent angiogenesis as well as the spread of metastasis (Borek 2004). On the other hand, green leafy vegetables, fruits, and dietary quercetin also helped to reduce lung, breast, stomach, colorectal, and prostate cancer (Arsova-Sarafinovska and Dimovski 2013). In a similar way, 6-hydroxy-2,2-dimethyl-3-chrom, rosmarinic acid, 1-O-β-glucopyranosyl-1,4-dihydroxy-2-prenylbenzene, β-sitosterol 3-glucoside, and β-sitosterol isolated from methanol extract of Gastrocotyle hispida have shown potent antioxidant and anticancer property (Shahat et al. 2019).
16.2.2 Inhibition of Cellular Mechanisms
16.2.2.1 Cell Proliferation
A condition in which cell number increases, resulting in cell growth and cell division is called as cell proliferation. However, abnormal cell cycle results in accumulation of abnormal cells and its over-proliferation as well. This kind of abnormal and uncontrolled cell growth leads to distinct kinds of cancer (López-Sáez et al. 1998). So, inhibiting cell proliferation of abnormal cells as one of the cellular mechanisms is considered as one of the anticancer assets. It is revealed that polyphenols obtained from green tea also perform as chemopreventive mediators against prostate cancer by inhibiting proliferation and inducing apoptosis in cell cultures (Adhami et al. 2004), while methanolic extract of Oxygonum sinuatum inhibited proliferation and migration of mammalian endothelial cell (Njuguna et al. 2018). Moreover, anticancer potential of daily diet phytochemical ingredients like curcumin, sulforaphane, lycopene, plus quercetin was studied in colon epithelial as well as cancer cells. Studies here examined mitochondrial activity, DNA synthesis, and lactate dehydrogenase release tests, which are found to inhibit proliferation of colon cancer cell besides not harming the normal colon epithelial cells (Langner et al. 2019), whereas microtubule-targeting agents revealed inhibition potential of the proliferation of cancerous cells. The first group of antimitotic agents was paclitaxel and vinca alkaloids which revealed the capability to inhibit proliferation of cancerous cell (Mukhtar et al. 2014). In a similar way, phytochemicals like vincristine and vinblastine when treated to patients with acute lymphocytic leukemia, testicular cancer, as well as Hodgkin’s lymphoma successfully inhibited cell proliferation. Similarly, flavopiridol, fangchinoline, 5,3′-dihydroxy-3,6,7,8,4′-pentamethoxyflavone, isorhamnetin, resveratrol, silymarin, and indole-3-carbinol also inhibited proliferation of numerous cancerous cells including colon, breast, kidney, pancreas, prostate, head/neck, endometrial, leukemia, lung, colorectal, bladder, myeloma cancer cell lines, and various other human tumor cells (Bailon-Moscoso et al. 2017).
16.2.2.2 Cell Adhesion and Invasion
A process in which cells form contact with each other or with their substratum through specialized protein complex is called as cell adhesion (Oh et al. 2012), whereas cell invasion is related to cell migration and navigation through extracellular matrix within tissues or to infiltrate neighboring tissue (Pavese et al. 2010). For cancer, adhesion and invasion are the shortest extension and penetration by cancer cells into neighboring tissue for the formation of metastasis. So, inhibiting adhesion and invasion mechanism of cancer cells can be considered as one of the key steps in cancer chemoprevention therapy. Fisetin from strawberries and apples, curcumin from Curcuma longa L., and rosmarinic acid found in various medicinal herbs including, thyme, lemon balm, rosemary, sage, oregano, peppermint, as well as culinary spices revealed inhibition potential of cell adhesion, migration, and invasion with variations in their dosages (Wang et al. 2012). Here, curcumin also revealed anticancer property by downregulating the transcription factors, repressing genes responsible for cell adhesion molecules, as well as by decreasing metastasis (Rahmani et al. 2014). Similarly, thymoquinone isolated from seeds of Nigella sativa showed anti-metastatic potential by inhibiting cell invasion, cell migration, cell adhesion, and cytoskeletal reorganization when studied on human renal carcinoma cell (Liou et al. 2019), while garlic contains diallyl trisulfide as organosulfur compound reduced matrix metalloproteinase-2 and metalloproteinase-9 (MMP-2 and MMP-9) expressions along with the inhibition of melanoma cell invasion and migration in humans. Here, diallyl trisulfide also disrupted the integrin signal pathways and henceforth inhibited adhesion (Wang et al. 2017). In a similar way, gallic acid, carnosol, caffeic acid, capsaicin, chlorogenic acid, 6-gingerol, 6-shogaol, and their resultant derivatives were proposed to have anti-invasion and anti-metastasis potential (Weng and Yen 2012). In the context of plant extracts, Porphyra tenera extracts were responsible for inhibition of cell adhesion, migration, and cell invasion in human hepatoma cancer cells. Here, the extracts eventually inhibited gelatinase-A/-B activities (MMP-2/ MMP-9) as well as increased tissue inhibitors of MMP-1/-2 expression by showing anti-metastatic exploit (Do Thi and Hwang 2014), whereas in human lung squamous carcinoma cells, tannin fractions of Fructus phyllanthi were responsible for inhibition of cell migration and invasion showing decrease in MMP expressions through regulation of mitogen-activated protein kinases (MAPK) pathway (Zhao et al. 2015). Likewise, root extracts of Withania somnifera used in even a small concentration have the potential for inhibition of breast cancer metastasis showing minimal antagonistic properties in rats (Yang et al. 2013).
16.2.2.3 Signal Transduction Pathways
A process in which molecular signals are transmitted from outside to inside the cells is called signal transduction. Generally, these signals affect different functions of cells like cell division as well as cell death. But, cells with permanent changes in signal transduction molecule may form cancer (Liem et al. 2002). So, inhibiting these signals in cancer cells can promote the killing of the cancer cell. Hence, the search for inhibitors of signal transduction pathway could be one of the therapeutic approaches in cancer treatment. The core targets for inhibiting signal transduction pathways are activator protein-1 (AP-1), MAPK, NF-κB, c-myc expression, protein kinases C (PKC), phosphoinositide 3-kinase (PI3K), as well as abnormal cyclooxygenase-2 (COX-2) (Gupta et al. 2017). Ginger consisting of 10-gingerol and 6-gingerol component showed potency to control PI3K/Akt pathway signal transduction which links to anticancer property, whereas sulforaphane found in cruciferous vegetables studied on ovarian cancer cell lines showed an appropriate reduction in PI3K. It also activated phosphorylated levels of Akt and Akt proteins (Suvarna et al. 2017). Similarly, apigenin in endometrial cancer cells has shown particular actions on AP-1 to regulate MAPK pathway, whereas coumarin showed involvement in downregulating pathways like NF-κB, MAPK, as well as Akt. While in combination with paclitaxel, it encouraged a synergistic reduction in the occurrence of the tumor as well as tumor volume when studied in mice (Farrand et al. 2014). However, curcumin, cyanidine, rosmarinic acid, sulforaphane, triterpenoids, resveratrol, and tocopherols were found to inhibit or suppress the activity of COX-2 gene expression in various cancers (Wang et al. 2012; Gupta et al. 2017). Also, in vitro and in vivo trials demonstrated catechol to inhibit c-myc phosphorylation in mice suffering from lung cancer (Lim et al. 2016). Additionally, eugenol found in cloves, bay leaves, nutmeg, cinnamon, and basil showed potential to downregulate the c-myc expression (Ng et al. 2018). Later, in vitro and in vivo studies for anticancer potential carried out using quercetin in combination with cisplatin showed inhibition of the PKC pathway (Purnamasari et al. 2019). Some phytochemicals like benzyl isothiocyanate, genistein, thymoquinone, silibinin, epigallocatechin gallate, parthenolide, naringenin, isoliquiritigenin, ginsenosides, and sulforaphane also suppressed breast carcinoma by several signaling transduction pathways (Younas et al. 2018).
16.2.2.4 Oncogene Expression
Gene responsible to cause cancer is called an oncogene, while a normal gene is a proto-oncogene that may turn to oncogene due to increase in expression or mutation. Generally, these proto-oncogenes code for proteins which regulates cell differentiation and their growth (Croce 2008). So, inhibition of oncogene expression or suppression of proto-oncogene expression using phytochemicals can also help in cancer chemoprevention. Basically, oncogenes are classified in six different categories
-
1.
Cytoplasmic tyrosine kinases including different families (like Src, Syk-ZAP-70, BTK family of tyrosine kinases, and Ab1 gene in chronic myeloid leukemia).
-
2.
Growth factor or mitogens (C-Sis).
-
3.
Receptor tyrosine kinases (including human epidermal growth factor receptor 2 (HER2/neu), epidermal growth factor receptor (EGFR), vascular endothelial growth factor receptor (VEGFR), and platelet-derived growth factor receptor (PDGFR)).
-
4.
Cytoplasmic serine/threonine kinases (including Raf kinases and cyclin-dependent kinases (CDK)).
-
5.
Regulatory GTPases (including Ras proteins).
-
6.
Transcription factors (including myc gene, erb A, jun, ets, fos, and myb) (Croce 2008).Flavonoids inhibiting oncogene expressions were classified based on their activities on cancer cells. Some of them are particularized here. Flavones like luteolin interfered in JNK, p38, and Akt signaling pathways and led to induce programmed cell death along with autophagy in ANA-1 cells. It also showed the potential to inhibit beclin-1 and Bcl-2 together with activation of caspase-3 and -8, while flavonols like galangin induced apoptosis-targeted signals like Akt/PI3K/mTOR resulting in inhibition of cell proliferation in human kidney cancers. However, flavononols like taxifolin inhibited mammary carcinogenesis in LXR-mTOR/Maf1/PTEN and CYP1A1- and CYP1B1-mediated cancers. Similarly, flavans like catechin inhibit programmed cell death ligand 1 to treat lung tumor. Anthocyanidins like delphinidin when studied in human osteosarcoma cell lines showed interference in ERK2/p38MAPK pathway to promote apoptosis and epithelial-mesenchymal transition process (Chirumbolo et al. 2018). A preceding study discussed five phytochemicals, namely, epigallocatechin gallate, kaempferol, genistein, morin, and caffeic acid phenethyl ester for their role in cancer remedy through modulating coding as well as non-coding genes. Some of them are elaborated here. Epigallocatechin gallate showed potency to inhibit expression of neurogenic locus notch homolog protein 2 along with transcription factor HES1 in colorectal cancer and can also target Ras-GTPase-activating protein-binding protein 1 which have chemopreventive effects in lung cancer. Also, kaempferol via downregulating c-myc helps to stimulate ovarian cancer cell apoptosis and can promote the cause of cellular death by reducing Bcl-2 expression and increasing Bax expressions, while genistein helps to target some intermediary signaling pathways like Akt, NFκB, Wnt, and p53 to modulate antitumor activities. Similarly, morin when targeted to Bax, Bcl-2, and cytochrome c in human leukemia cells showed caspase-dependent apoptosis by means of the intrinsic pathway. Likewise, caffeic acid phenethyl ester targets the NFκB transcription factor to promote programmed cell death in various cell lines (Budisan et al. 2017). Moreover, capsaicin was responsible for the transformation of phenotype in H-ras MCF-10A cells and inhibiting its growth with time-dependent activation of p38 and c- Jun N-terminal kinase-1 along with deactivating ERK-1 and ERK-2, resulting in induction of apoptosis via caspases-3 and fragmentation of DNA. Similarly, rocaglamide as leukemia (Jurkat T, AML) cells treatment showed interference in the intrinsic death pathway by modulating MAPK activities and thereby showing the induction of apoptosis (Kaur et al. 2018). In a similar way, gingerols, emodin, ginsenoside RG3, honokiol, parthenolide, triptolide, wogonin, thymoquinone, resveratrol, andrographolide, quercetin, apigenin, and many more phytochemicals have conferred their ability to inhibit PI3K pathways targeting Akt in several human cancers (Suvarna et al. 2017).
16.2.3 Induction of Cellular Activities
16.2.3.1 Cell Differentiation
A progression in which cells become specialized so as to perform specific functions including neuron, liver cells, or blood cells is referred to as cell differentiation, whereas in cancer, well-defined cancer cells appear more similar to that of normal cells and tend to spread and grow slower than that of undifferentiated cancerous cells. Here, a differentiation term differs for respective types of cancers (Yan and Liu 2016). Hence, drugs inducing differentiation are deliberated as one of the promising lines of attack in cancer treatment. In this regard, all-trans retinoic acid (also called tretinoin), one of the anti-acne medications also used for acute promyelocytic leukemia, was found to induce differentiation in various types of cells and thus effectively used in cancer prevention and treatment (Liu et al. 2015). Similarly, compounds like hydroxyzine, promethazine, levomepromazine, and buclizine were responsible for inhibition of cancer cell growth via direct binding to the translationally controlled tumor protein expression and inducing the cell differentiation of leukemia cells and breast cancer (Seo et al. 2017). In a similar manner, natural phenol resveratrol from peanuts, red grapes skin, and other fruits when studied in human promyelocytic leukemia induced cell differentiation and thus possessed cancer chemopreventive potential (Wang et al. 2012), while a natural isoflavon, i.e., genistein, found in Genista tinctoria, soybeans, chickpeas, and other legumes promotes melanoma cell differentiation by stabilizing protein-linked DNA strand breakage as well as by inhibition of angiogenesis (Ng et al. 2018). Moreover, methanolic extract of Biophytum sensitivum Dc plant when tested on Ehrlich ascites carcinoma cells and Dalton’s lymphoma ascites showed increased count of white blood cells and bone marrow cells along with enhancement of stem cell differentiation (Manisha and Kumar 2018). Additionally, fish oil fats also considered as food phytochemicals were found to increase colon cell differentiation rates (Ferrari 2004).
16.2.3.2 Cell Apoptosis
Cell apoptosis means cellular suicide. It is also mentioned as a process of programmed cell death or self-destruction of cells. Cell necrosis is the premature death of living tissues and cells (Wong 2011). Here, flaws in mechanisms of physiological apoptosis or necrosis contribute to unrestrained cell expansion leading to the progression and development of cancer. So, inducing cell apoptosis or necrosis is an utmost important strategy in cancer therapy. The chief polyphenol catechin called epigallocatechin-o-gallate isolated from green tea extract (Camellia sinensis) interfering in cyclic guanosine monophosphate-dependent pathway or acid sphingomyelinase pathway in chronic myeloid leukemia cells played a crucial role to induce cellular death providing anticancer properties (Huang et al. 2015). Hence, epigallocatechin-o-gallate can be useful for the treatment of bladder, cervical, brain, and prostate cancer (Wang et al. 2012). Similarly, the essential oil obtained from Myrtus communis L. revealed cytotoxic activity by apoptosis mechanism thereby suggesting it as a natural anticancer compound, while a compound myrtucommulone derived from leaves of M. communis revealed increased caspases 3 and 9 activities. It also further released nucleosome in cytochrome c as well as cytosol from mitochondria resulting in DNA fragmentation cleavage along with poly-ADP-ribose polymerases associated with cell apoptosis (Harassi and Ajouaoi 2019). Likewise, curcumin found in turmeric when administered in human lung cancer cells induced apoptosis. Studies also revealed that curcumin helps to induce death in pancreatic adenocarcinoma cells and reduce numerous apoptosis inhibitors (Radhakrishna Pillai et al. 2004; Díaz Osterman et al. 2016). However, a triterpene like-cucurbitane called as 3β,7β-dihydroxy-25-methoxycucurbita-5,23-diene-19-al found in Momordica charantia (a wild bitter gourd) helped to induce autophagy and apoptosis in breast cancer cells via peroxisome proliferator-activated receptors (PPAR)-γ (Weng et al. 2013). Phytochemicals of Allium sativum clinically tested in colorectal and pancreatic cancer patients increased number and activity of natural killer cells (Hosseini and Ghorbani 2015), whereas saffron a rich carotenoid includes two major components, i.e., crocin and crocetin. According to the in vitro, in vivo and preclinical facts, saffron and its constituents when consumed in daily diet revealed antitumor potential (Bhandari 2015), while saffron isolated from Crocus sativus L. exhibited apoptotic and cytotoxic induction in lung cancer cells (A549) (Samarghandian et al. 2013). Two different concentrations (i.e., 0.1% and 1%) of Thymus vulgaris L. extract were studied in vivo and in vitro against breast carcinoma. Both doses showed a significant decrease in the mitotic activity index. Moreover, the 4 T1 (breast cancer cell line derived from mammary gland tissue of mice) necrosis/tumor area was reduced to 85% and 84% by treatment with 0.1% and 1% of extract, respectively, as compared to the control rat models. Additionally, the 1% extract reduced the frequency of tumors by 53% in comparison to control (Kubatka et al. 2019). Similarly, anticancer potential of fruit and leaf extracts of Ficus carica studied in Huh7it cells revealed the occurrence of necrosis and apoptosis at a high percentage in the presence of leaf extracts (Purnamasari et al. 2019). Also, various mechanisms like apoptosis, cytotoxicity, autophagy, and interference with signaling pathways were observed in the presence of Piper nigrum revealing anticancer potential against colon, prostate, cervical, and breast cancer cell lines (Takooree et al. 2019).
16.2.3.3 Tumor Suppressor Gene Expression
Tumor suppressor genes are mentioned as normal genes with the ability to repair DNA, delay cell division, or decide cell death. When the tumor suppressor gene loses the ability to work in a proper way, cells grow in an uncontrolled manner which later forms cancer (Guo et al. 2014). So, inducing expression of tumor suppressor genes may possibly be beneficial in cancer therapy. The first tumor suppressor gene discovered is the retinoblastoma (Rb) gene followed by pVHL, APC, CD95, ST5, YPEL3, ST7, ST14, Skp2, p27, PTEN, and one of the most important ones being the p53 gene (Osborne et al. 2004). Recent reports suggest that phytochemicals induce the expressions of tumor suppressor genes. In this regard, luteolin, a flavonoid, induced Fas/CD95 expression and activated caspase-8 in HLF hepatoma cells. It was also observed that luteolin has the ability to decrease Tyr phosphorylation of STAT3 (which is recognized to act as a negative regulator of Fas/CD95 transcription) and increase the expression of Fas/CD95 (Imran et al. 2019). Curcumin from turmeric has potential to control the progression of tumor cells by inducing tumor suppressor pathways p53 and p21. It also upregulates p16 and numerous other tumor suppressors, JAK2 and STAT3 pathway inhibition, which leads to decrease in smooth muscle actin and migration/invasion capability of breast cancer-associated fibroblasts (Wang et al. 2012; Younas et al. 2018). However, kaempferol from tea, broccoli, and grapefruit interferes in the intrinsic pathway and activates p53 to induce apoptosis in the ovarian cancer cell. Later, kaempferol also proved to induce PTEN expression and Akt inhibition in bladder cancer (Wang et al. 2012; Budisan et al. 2017). Induction of p53, as well as inhibition of STAT3 and NF-κB, was observed due to apigenin in HER2-overexpressing MCF-7 breast carcinoma cells by extrinsic pathway (Younas et al. 2018). In another recent study, it was found that the major component of Ficus carica quercetin when individually treated with HepG2 liver cancer cells reported to stabilize p53 and increase Bax/Bcl-2 ratio leading to apoptosis (Purnamasari et al. 2019).
16.2.3.4 Cell Cycle Arrest
A situation when the cell detects any defects or any damage that occurs in DNA, an arrest occurs through several mechanisms to delay or halt the cell cycle. In cancer cells, genetic mutations occur which leads to regulatory malfunctioning and uncontrolled cell proliferation (Rastogi and Mishra 2012). Hence, induction of cell cycle arrest in cancer cells using phytochemicals may be considered as another cancer therapy strategies. In this context, various experimental and preclinical procedures proved that tea flavonoids containing epigallocatechin-3-gallate possess a key role in different cancer treatments via inducing cell cycle arrest (Gödeke et al. 2013). In addition, ethyl acetate extract of Annona muricata leaves showed cell cycle arrest in G1 phase associating antiproliferative effect and induced apoptosis through mitochondria-mediated pathway when studied against colon and lung cancer cells individually (Zorofchian Moghadamtousi et al. 2014). Studies based on breast cancer cell lines show that different phytochemicals help to promote cell cycle arrest in different ways. Few of them includes ginsenoside Rg5, a-mangostin, apigenin, isoliquiritigenin, sulforaphane, and curcumin. Here, apigenin has the potential of inducing cell cycle arrest by suppressing CDK-1, cyclin A, and B that are important for G2 to M phase transition in the cell cycle, while ginsenoside Rg5 helped arrest at G0/G1 phase of the cell cycle by upregulating p21, p53, as well as p15 and downregulating CDK-4, cyclin E2, and cyclin D1in breast cancer cell lines. Additionally, curcumin along with folic acid enhanced arrest at the G2/M phase of the cell cycle (Younas et al. 2018), while prostate cancer cells treated with caffeic acid phenethyl ester regulated the expression of Skp2, p21, p53, Cip1, as well as p27Kip1 genes leading to induction of cell cycle arrest and inhibition of cell growth (Budisan et al. 2017). Similarly, several mechanisms like activating p53, cell cycle arrests in G0/G1 phase and S phase were triggered by quercetin in leukemia and colorectal carcinoma, respectively. Additionally, G2/M phase arrest was also triggered by quercetin in breast cancer, esophageal cancer, as well as leukemia cells (Purnamasari et al. 2019). Moreover, the aqueous extract of white coca tea to treat human prostate cancer cells revealed cell cycle arrest in G2/M phase when studied in vitro and in vivo, while isoquercetin in addition to silymarin blocked G1 phase of the cell cycle when studied in human liver cells as well as G1/S phase when studied in prostate, ovary, colon, bladder, lung, and breast tumor cells. Similarly, propolis arrested S/G2 phase of cell cycle and inhibited the growth of tumor (Bailon-Moscoso et al. 2017). In a similar manner, sugiol, oridonin, honokiol, gallic acid, and indole-3-carbinol arrest cell cycle in the human breast, prostate, colon, and other different cancerous cell lines (Kaur et al. 2018), while lycopene induced arrest at G0/G1 phase of cell cycle and/or accumulated at S phase in colon cancer cells. Moreover, a recent study shows the synergistic effect of a cocktail containing resveratrol, genistein, C-phycocyanin, indol-3-carbinol, curcumin, and quercetin-induced cell cycle arrest in breast cancer (Langner et al. 2019).
16.2.4 Other Mechanisms
16.2.4.1 Enzyme Induction and Enhancing Detoxification
Generally, enzymes help to accelerate the chemical reaction in the body and participate in many cell functions including cell signaling, growth, and division. Hence, induction of enzymes activity through phytochemicals is one of the trending approaches towards cancer therapy. Therefore, glutathione S-transferases (maintain integrity of cells and protect against DNA damage through catalyzing conjugation of glutathione), quinone reductases (the enzymes present in cells that make certain molecules less toxic), epoxide hydrolase, glucuronosyl transferase (catalyzes broad range of glucuronidation of xenobiotic along with endogenous compounds), and sulfotransferase (enzymes that catalyze sulfonation) are few enzymes involved in phase II metabolism and induced by some phytochemicals or its bioactive compounds which are highlighted below (Dellinger et al. 2012; Abdull Razis et al. 2014; Schnekenburger et al. 2014). Camptothecin can be obtained from numerous plants including Canzptotheca acirminata and Mappia foetida that have the potential to target topoisomerase I (enzymes involved in DNA supercoils relaxation) to contribute to antitumor activity. Similarly, compounds like 20-(S)- camptothecin and 20-(S)-9-nitrocamptothecin have antitumor potential when studied in prostate cancer, melanoma, cholangiocarcinoma, breast carcinoma, and ovarian carcinoma, while curcumin decreased lymphocytic GSTs activity (family of phase II detoxification enzymes) (Hosseini and Ghorbani 2015). Moreover, phytochemicals present in vegetables including spinach, leaf lettuce, broccoli, cabbage, cauliflower, Brussels sprouts, green beans, carrots, celery, ginger, green onions, leeks, and asparagus as well as compounds isolated from them like butylated hydroxyanisole, benzyl isothiocyanate, allyl sulfide, and dimethyl fumarate induced enzymes like GSTs, quinone reductase, and related detoxification systems followed by activating apoptosis in human colon carcinoma cells (Kirlin et al. 1999). In addition, alantolactone found in medicinal plants like Inula racemosa, Inula helenium L., Inula japonica, Radix inulae, and Aucklandia lappa was observed to induce detoxifying enzymes by activating PI3K and JNK signaling pathways (Millimouno et al. 2014). Similarly, phenethyl isothiocyanate, isolated from cruciferous vegetables such as watercress, modulated carcinogen-metabolizing enzyme systems. Here, phenethyl isothiocyanate induced sulfotransferase, glucuronosyl transferase, and epoxide hydrolase levels when studied in mice (Abdull Razis et al. 2014). However, UDP-glucuronosyl-transferase family of enzymes also showed the potential of detoxification of carcinogens along with clearance of anticancer drugs (Dellinger et al. 2012). Likewise, limonene and sobrerol increased phase II enzyme activities and prohibited carcinogenesis initiation in rat with breast cancer (Bruno and Njar 2007).
16.2.4.2 Enzyme Inhibition
Enzyme inhibition is a concept where the action of an enzyme is blocked. Thus, phytochemicals acting as enzyme inhibitors may block certain enzymes that are required for the cancer cell to grow. Histone deacetylases inhibitors are helpful to induce phenotypes in different transformed cells like growth arrest, mitotic cell death, apoptosis, and reactive oxygen species-assisted cell death. Here, green tea polyphenols containing a mixture of epicatechin monomers inhibited the growth of histone deacetylases activity and induced death of melanoma cells (Prasad and Katiyar 2015), while isothiocyanates, sulforaphane, and erucen phenylhexyl isothiocyanates are potent histone deacetylases inhibitors in prostate, lung, pancreatic, and bladder cancer therapy (Mitsiogianni et al. 2019). Similarly, phytochemicals like quercetin, apigenin, curcumin, indirubin, isothiocyanates, butyrate, and baicalin and baicalein (obtained from Scutellaria baicalensis) were reported as histone deacetylases inhibitors for anticancer therapy (Evans and Ferguson 2018). Likewise, COX-2 enzymes (convert arachidonic acid to prostaglandins) are found to be overexpressed and upregulated in many cancers. In this perspective, curcumin was found to act as COX-2 inhibitors in cell lines of colon cancer and inhibited critical stage of tumor initiation (Rahmani et al. 2014), while other compounds like tocopherols, tocotrienols, phytosterols, pterostilbene, piceatannol, and resveratrol showed their efficacy as COX-2 inhibitors (Soldati et al. 2018). Additionally, plant protease inhibitors also show their applicability in cancer therapy and have been reviewed by several authors. In this regard, protease inhibitors present in Cicer arietinum L as well as Bauhinia seeds (rich in serine and cysteine) inhibited cell viability in prostate cancer and breast cancer, whereas Enterolobium contortisiliquum trypsin inhibitor blocked the activity of trypsin, plasmin, chymotrypsin, and kallikrein which leads to inhibit cell adhesion, invasion, as well as migration in gastric cancer. Moreover, seeds of Glycine max possess both Kunitz-type inhibitors and Bowman-Birk inhibitors which are helpful in colorectal, colon, prostate, ovarian, and breast cancers, whereas black-eyed pea trypsin/chymotrypsin inhibitor induced apoptosis in breast cancer cells (Srikanth and Chen 2016).
16.2.4.3 Enhancement of Immune Function and Surveillance
The situation when the immune system identifies and removes the cancerous cells is called immune surveillance (Cook et al. 2018). The immune system works for cancer cell removal by three steps, i.e., exclusion (elimination), equilibrium, and escape. In the exclusion type of mechanism, identification and destruction of cancer cells is taken care by the immune system. In the equilibrium type of mechanism, cancer cells are wiped out completely by the immune system. In escape type of mechanism, the immune system is helpless in controlling the proliferation of cancerous cells and hence unable to eradicate tumor (Nouroz et al. 2016). Numerous phytochemicals like isothiocyanates, genistein, lycopene, curcumin, and glucosinolates are reported to aid the regression of tumors in a few clinical trials. Furthermore, boosting the immune system was claimed by phytochemicals like flavonoids, zinc, vitamin C, and omega-3 fatty acids (Vinay et al. 2015). Some of the reviews articulate that inhibitors of the CDK-4 and CDK-6 in cancer cells were initially designed to inhibit cell cycle progression and its proliferation. But these inhibitors of CDKs proved to have an indirect effect in activation of immune surveillance. So, CDK inhibitors further studied found phytochemicals like flavopiridol, glycyrrhizin, rosamultic acid, proanthocyanidins, berberine, isoliquiritigenin, resveratrol, propolis, nar (flavanone), and indole-3-carbinol have potential role in anticancer chemotherapeutics (Bailon-Moscoso et al. 2017; Chaikovsky and Sage 2018). Enhancing natural killer cells is one of the approaches to destroy tumor by perforin and granzyme that are essential for tumor cell death as well as immune surveillance. One of the important roles of natural killer cells is to kill virally infected and cancerous cells. Phytochemicals found in Agaricus blazei teas, Andrographis paniculata, Ganoderma lucidum, nitrogenated soy extract, as well as natural products like ascorbic acid, immune modulator mix, transfer factor plus, selenium, and vitamin E helped to control cancer by enhancing the natural killer cells efficiency (Latorre et al. 2014; Nouroz et al. 2016). Similarly, resveratrol, polyphenols present in tea like epicatechin-3-gallate and epigallocatechin-3-gallate, improved elimination of transformed cells and enhanced innate immune surveillance (Kotecha et al. 2016). Some medicinal plant extracts or phytochemicals show promising cancer immunotherapeutic properties with different strategies and are discussed in several reviews. A recent review discusses that shikonin and hypericin helped to enhance tumor vaccine efficacy to induce immunogenic cell death in melanoma and orthotopic high-grade glioma mice models, respectively. Similarly, Astragalus membranaceus, Codonopsis pilosulae, and Dioscorea alata var. purpurea extract as well as polysaccharides from Ganoderma lucidum, Anoectochilus formosanus, and Schisandra chinensis showed specific immune cell activation or cell-based vaccine immunity potential in the tumor microenvironment in carcinoma tumor, lung cancer patient, and melanoma mice tumor models. Moreover, artemisinin, paclitaxel, isothiocyanate, berberine, mistletoe extract, green tea extract, broccoli, resveratrol, curcumin, noscapine and its derivatives, and piperine were responsible to suppress oxidative stress in the tumor microenvironment (Yin et al. 2017).
16.2.4.4 Anti-Angiogenesis
Formation of new blood cells/vessels is termed as angiogenesis. It involves growth, differentiation, and migration of endothelial cells. Generally, tumor cells also need blood nutrients for their growth. So, chemical signals are sent by tumor cells to stimulate blood vessel growth by which it carries blood to the tumor. But, angiogenesis inhibitors (also called as anti-angiogenesis) block the nutrients and allow tumors and destroy circulating pathway for tumor cells which leads to its starvation. Hence, these angiogenesis inhibitors are important in cancer treatment (Nishida et al. 2006). Angiogenesis can be modulated by several steps such as vascular endothelial growth factor (VEGF), basic fibroblast growth factor (bFGF), hypoxia-inducible factor-1α (HIF-1α) signaling pathway, endothelial cell proliferation, as well as migration or MMP activity (Mirossay et al. 2018). Quercetin, cardamonin, kaempferol, luteolin, licochalcone E, rhamnazin, paxillin, epigallocatechin-3-gallate, barbigerone, galangin, myricetin, licochalcone A, chrysin, hispidulin, nobiletin, panduratin A, naringenin, xanthoangelol, xanthohumol, isoxanthohumol, eupatorin, butein, delphinidin, isoliquiritigenin, neoisoliquiritigenin, hydroxy safflower yellow A, 4′-acetoamido-4-hydroxychalcone, 1,3-diphenyl-propenone, 4-hydroxychalcone, artemisinin, taxifolin, allyl isothiocyanate, (E)-2-(4′-methoxybenzylidene)-1-benzosuberone, resveratrol, and wogonin repressed VEGF signaling pathway either because of direct effect on VEGF/VEGFR2 or by modulating VEGFR2-mediated downstream signaling. Also, chrysin, a 5,7-dihydroxyflavon, luteolin, and apigenin were found to inhibit the interleukin-6 (IL-6) pathway, while nobiletin, kaempferol, alliin, hydroxy safflower yellow A, emodin, 4-hydroxychalcone, and genistein were responsible to inhibit bFGF signaling pathway. Similarly, wogonin, astaxanthin, isoliquiritigenin, neoisoliquiritigenin, epigallocatechin-3-gallate, theaflavin-3,3′-digallate, combretastatin, oleuropein, γ-tocotrienol, nobiletin, flavopiridol, curcumin, and caffeic acid were responsible to inhibit HIF-1 signaling pathway. In addition, quercetin, xanthohumol, isoxanthohumol, curcumin, isoliquiritigenin, neoisoliquiritigenin, butein, chrysin, kaempferol, 3-hydroxyflavon, astaxanthin, nobiletin, wogonin, luteolin, thymoquinone, panduratin A, hydroxy safflower yellow A, piperine, zerumbone, myricetin, and epigallocatechin-3-gallate were found to inhibit different MMPs, specifically MMP-2 and MMP-9 (Jeong et al. 2011; Ean Jeong Seo 2013; Mirossay et al. 2018; Younas et al. 2018; Rajasekar et al. 2019).
16.3 Conclusions and Future Prospects
Unlike chemotherapeutic drugs, phytochemicals are meddling with all three stages of carcinogenesis, i.e., initiation, promotion, or progression, for protection against cancer. In addition, these phytochemicals also show a synergistic effect when used with chemotherapy medications. Additionally, they are coupled with reduced adverse effects and boosted quality and life span of the patient. Phytochemicals also help to boost the immune response of host’s cells against carcinogenesis explosion. Moreover, they support to decrease, bypass, or silence molecular mechanism underlying chemoresistance including signaling cascades, cell cycle effectors, drug transporters, and nuclear transcription factors. On the other hand, plenty of outcomes regarding phytochemicals and cancer therapy from in vitro, in vivo, and preclinical trials are being carried out every day showing success to some extent. Considering this, it had been predicted that numerous cancers could be prevented just by upholding proper lifestyle alterations, while interfaces of the phytochemicals as cancer medication may uncover some economic, safe, and nontoxic anticancer therapeutic in the future. Besides, further efforts are justifiable to appreciate potency, metabolism, stabilities, polymorphism, toxicities, drug–drug interactions, pharmacokinetics, and dynamics, along with the formulations, degradation, and dosages regimens of phytochemicals.
Abbreviations
- ACS:
-
American Cancer Society
- Akt:
-
Protein kinase B
- AML:
-
Acute myeloid leukemia
- AP-1:
-
Activator protein-1
- Bax:
-
Bcl-2-associated X protein
- Bcl-2:
-
B-cell lymphoma 2
- bFGF:
-
Basic fibroblast growth factor
- BTK:
-
Bruton’s tyrosine kinase
- CDK:
-
Cyclin-dependent kinases
- c-myc:
-
c-Myelocytomatosis
- COX-2:
-
Cyclooxygenase-2
- CYP1A1:
-
Cytochrome P450 family 1 subfamily A member 1
- CYP1B1:
-
Cytochrome P450 family 1 subfamily B member 1
- DNA:
-
Deoxyribonucleic acid
- EGFR:
-
Epidermal growth factor receptor
- ERK2:
-
Extracellular signal-regulated kinases 2
- Fas/CD95:
-
Apoptosis antigen 1 (cluster of differentiation 95)
- GSTs:
-
Glutathione S-transferases
- HDACs:
-
Histone deacetylases
- HepG2:
-
Human liver cancer cell line
- HER2/neu:
-
Human epidermal growth factor receptor-2
- HIF-1α:
-
Hypoxia-inducible factor-1α
- HIV:
-
Human immunodeficiency virus
- HPV:
-
Human papilloma virus
- i.e.,:
-
That is
- ICD-O:
-
International Classification of Diseases for Oncology
- JAK2:
-
Janus kinase 2
- MAPK:
-
Mitogen-activated protein kinase
- MCF-7:
-
Breast cancer cell line
- MMP:
-
Matrix metalloproteinase
- mTOR:
-
Mammalian target of rapamycin
- NCDB:
-
National Cancer Database
- NF- κB:
-
Nuclear factor-kappa B
- PDGFR:
-
Platelet-derived growth factor receptor
- pHDACs:
-
Pan-histone deacetylases
- PI3K:
-
Phosphoinositide 3-kinase
- PKC:
-
Protein kinases C
- PPAR:
-
Peroxisome proliferator-activated receptor
- PTEN:
-
Phosphatase and tensin homolog
- pVHL:
-
Van Hippel-Lindau tumor suppressor
- Raf:
-
Rapidly accelerated fibrosarcoma
- Ras:
-
Retrovirus-associated DNA sequences
- Rb:
-
Retinoblastoma
- Skp2:
-
S-phase kinase-associated protein 2
- Src:
-
Sarcoma
- STAT3:
-
Signal transducer and activator of transcription
- Syk-ZAP-70:
-
Spleen tyrosine kinase-zeta-chain-associated protein kinase 70
- UV:
-
Ultraviolet
- VEGF:
-
Vascular endothelial factor
- VEGFR:
-
Vascular endothelial growth factor receptor
- WHO:
-
World Health Organization
- YPEL3:
-
Yippee-like 3 gene
References
Abdull Razis AF, Mohd Noor N, Konsue N (2014) Induction of epoxide hydrolase, glucuronosyl transferase, and sulfotransferase by phenethyl isothiocyanate in male wistar albino rats. Biomed Res Int 391528. doi: https://doi.org/10.1155/2014/391528
Adhami VM, Siddiqui IA, Ahmad N et al (2004) Oral consumption of green tea polyphenols inhibits insulin-like growth factor-I—induced signaling in an autochthonous mouse model of prostate cancer. Cancer Res 64:8715–8722
Arsova-Sarafinovska Z, Dimovski AJ (2013) Natural antioxidants in cancer prevention. Maced Pharm Bull 59:3–14
Ayoub Z, Mehta A, Mishra SK (2018) Ethnopharmacological review of natural products in cancer prevention and therapy. Asian J Pharm Clin Res 11:32. https://doi.org/10.22159/ajpcr.2018.v11i6.24792
Baden LR (2015) Loss of fingerprints. N Engl J Med 372:e22. https://doi.org/10.1056/NEJMicm1409635
Bailon-Moscoso N, Cevallos-Solorzano G, Romero-Benavides JC, Orellana MIR (2017) Natural compounds as modulators of cell cycle arrest: application for anticancer chemotherapies. Curr Genomics 18:106–131. https://doi.org/10.2174/1389202917666160808125645
Bennett LL, Rojas S, Seefeldt T (2012) Role of antioxidants in the prevention of cancer. J Exp Clin Med 4:215–222. https://doi.org/10.1016/J.JECM.2012.06.001
Bhandari PR (2015) Crocus sativus L. (saffron) for cancer chemoprevention: a mini review. J Tradit Compl Med 5:81–87. https://doi.org/10.1016/j.jtcme.2014.10.009
Borek C (2004) Dietary antioxidants and human cancer. Integr Cancer Ther 3:333–341. https://doi.org/10.1177/1534735404270578
Bruno RD, Njar VCO (2007) Targeting cytochrome P450 enzymes: a new approach in anti-cancer drug development. Bioorg Med Chem 15:5047–5060. https://doi.org/10.1016/j.bmc.2007.05.046
Budisan L, Gulei D, Zanoaga OM et al (2017) Dietary intervention by phytochemicals and their role in modulating coding and non-coding genes in cancer. Int J Mol Sci 18:1178. https://doi.org/10.3390/ijms18061178
Chaikovsky AC, Sage J (2018) Beyond the cell cycle: enhancing the immune surveillance of tumors via CDK4/6 inhibition. Mol Cancer Res 16:1454–1457. https://doi.org/10.1158/1541-7786.MCR-18-0201
Chen Y, Wan Y, Wang Y et al (2011) Anticancer efficacy enhancement and attenuation of side effects of doxorubicin with titanium dioxide nanoparticles. Int J Nanomed 6:2321–2326. https://doi.org/10.1016/j.fct.2010.04.007
Cheng Y, Yang C, Shyur L (2016) Phytomedicine—modulating oxidative stress and the tumor microenvironment for cancer therapy. Pharmacol Res 72:128. https://doi.org/10.1016/j.phrs.2016.10.022
Chirumbolo S, Bjørklund G, Lysiuk R et al (2018) Targeting cancer with phytochemicals via their fine tuning of the cell survival signaling pathways. Int J Mol Sci 19:3568. https://doi.org/10.3390/ijms19113568
Cook KW, Durrant LG, Brentville VA (2018) Current strategies to enhance anti-tumour immunity. Biomedicine 6. https://doi.org/10.3390/biomedicines6020037
Croce CM (2008) Oncogenes and cancer. N Engl J Med 358:502–511. https://doi.org/10.1056/NEJMra072367
Dellinger RW, Matundan HH, Ahmed AS et al (2012) Anti-cancer drugs elicit re-expression of UDP-glucuronosyltransferases in melanoma cells. PLoS One 7:e47696. https://doi.org/10.1371/journal.pone.0047696
Díaz Osterman CJ, Gonda A, Stiff T et al (2016) Curcumin induces pancreatic adenocarcinoma cell death via reduction of the inhibitors of apoptosis. Pancreas 45:101–109. https://doi.org/10.1097/MPA.0000000000000411
Do Thi N, Hwang E-S (2014) Effects of laver extracts on adhesion, invasion, and migration in SK-Hep1 human hepatoma cancer cells. Biosci Biotechnol Biochem 78:1044–1051. https://doi.org/10.1080/09168451.2014.912116
Ean Jeong Seo OK (2013) Targeting angiogenesis by phytochemicals. Med Aromat Plants 02:08. https://doi.org/10.4172/2167-0412.1000134
El-Mowafy AM (2018) Phytomedicines: far beyond cytotoxicity in cancer therapy. Sole multitarget-polypharmacology, chemopreventive and safety profiles: combinatorial synergy, chemosensitization and mitigation of chemotherapy adverse-reactions. Nutr Food Toxicol 2:1–16
Evans LW, Ferguson BS (2018) Food bioactive HDAC inhibitors in the epigenetic regulation of heart failure. Nutrients 10:1120. https://doi.org/10.3390/nu10081120
Farrand L, Oh S-W, Song YS, Tsang BK (2014) Phytochemicals: a multitargeted approach to gynecologic cancer therapy Biomed Res Int 2014 890141. doi: https://doi.org/10.1155/2014/890141
Ferrari CKB (2004) Functional foods, herbs and nutraceuticals: towards biochemical mechanisms of healthy aging. Biogerontology 5:275–289. https://doi.org/10.1007/s10522-004-2566-z
Gödeke J, Maier S, Eichenmüller M et al (2013) Epigallocatechin-3-gallate inhibits hepatoblastoma growth by reactivating the Wnt inhibitor SFRP1. Nutr Cancer 65:1200–1207. https://doi.org/10.1080/01635581.2013.828085
Guo XE, Ngo B, Modrek AS, Lee W-H (2014) Targeting tumor suppressor networks for cancer therapeutics. Curr Drug Targets 15:2–16
Gupta VK, Singh R, Sharma B et al (2017) Phytochemicals mediated signalling pathways and their implications in cancer chemotherapy: challenges and opportunities in phytochemicals based drug development: a review. Biochem Compd 5:2. https://doi.org/10.7243/2052-9341-5-2
Harassi Y, Ajouaoi S (2019) Phytochemical analysis, cytotoxic and antioxidant activities of Myrtus communis essential oil from Morocco. J Compl Integr Med 16:1–8. https://doi.org/10.1515/jcim-2018-0100
Hosseini A, Ghorbani A (2015) Cancer therapy with phytochemicals : evidence from clinical studies. Avicenna J Phytomed 5:84–97
Huang Y, Kumazoe M, Bae J et al (2015) Green tea polyphenol epigallocatechin-O-gallate induces cell death by acid sphingomyelinase activation in chronic myeloid leukemia cells. Oncol Rep 34:1162–1168. https://doi.org/10.3892/or.2015.4086
Imran M, Rauf A, Abu-izneid T et al (2019) Luteolin, a flavonoid, as an anticancer agent : a review. Biomed Pharmacother 112:1–10. https://doi.org/10.1016/j.biopha.2019.108612
Jeong SJ, Koh W, Lee EO et al (2011) Antiangiogenic phytochemicals and medicinal herbs. Phyther Res 25:1–10. https://doi.org/10.1002/ptr.3224
Kaur V, Kumar M, Kumar A et al (2018) Pharmacotherapeutic potential of phytochemicals: implications in cancer chemoprevention and future perspectives. Biomed Pharmacother 97:564–586. https://doi.org/10.1016/j.biopha.2017.10.124
Kirlin WG, Cai J, DeLong MJ et al (1999) Dietary compounds that induce cancer preventive phase 2 enzymes activate apoptosis at comparable doses in HT29 colon carcinoma cells. J Nutr 129:1827–1835. https://doi.org/10.1093/jn/129.10.1827
Kotecha R, Takami A, Espinoza JL et al (2016) Dietary phytochemicals and cancer chemoprevention: a review of the clinical evidence. Oncotarget 7:52517–52529. https://doi.org/10.18632/oncotarget.9593
Kubatka P, Uramova S, Kello M et al (2019) Anticancer activities of Thymus vulgaris L. in experimental breast carcinoma in vivo and in vitro. Int J Mol Sci 20:29. https://doi.org/10.3390/ijms20071749
Kumar S, Ahmad MK, Waseem M et al (2015) Drug targets for cancer treatment: an overview. Med Chem (Los Angeles) 5:1–9. https://doi.org/10.4172/2161-0444.1000252
Langner E, Kinga M, Wojciech L (2019) Lycopene, sulforaphane, quercetin, and curcumin applied together show improved antiproliferative potential in colon cancer cells in vitro. J Food Biochem 43:e12802. https://doi.org/10.1111/jfbc.12802
Latorre AO, Greghi GF, Netto AS et al (2014) Selenium and vitamin E enriched diet increases NK cell cytotoxicity in cattle. Pesqui Veterinária Bras 34:1141–1145. https://doi.org/10.1590/S0100-736X2014001100018
Liem AA, Chamberlain MP, Wolf CR, Thompson AM (2002) The role of signal transduction in cancer treatment and drug resistance. Eur J Surg Oncol 28:679–684. https://doi.org/10.1053/EJSO.2002.1303
Lim DY, Shin SH, Lee M-H et al (2016) A natural small molecule, catechol, induces c-Myc degradation by directly targeting ERK2 in lung cancer. Oncotarget 7:35001–35014. https://doi.org/10.18632/oncotarget.9223
Liou Y, Hsieh Y, Hung T et al (2019) Thymoquinone inhibits metastasis of renal cell carcinoma cell 786-O-SI3 associating with downregulation of MMP-2 and u-PA and suppression of PI3K/Src signaling. Int J Med Sci 16:686–695. https://doi.org/10.7150/ijms.32763
Liu S-M, Chen W, Wang J (2015) Distinguishing between cancer cell differentiation and resistance induced by all-trans retinoic acid using transcriptional profiles and functional pathway analysis. Sci Rep 4:5577. https://doi.org/10.1038/srep05577
López-Sáez JF, de la Torre C, Pincheira J, Giménez-Martín G (1998) Cell proliferation and cancer. Histol Histopathol 13:1197–1214. https://doi.org/10.14670/HH-13.1197
Manisha, Kumar S (2018) Biophytum sensitivum dc.: a review. Int J Pharm Sci Res 9:27–36. https://doi.org/10.13040/IJPSR.0975-8232.9(1).27-36
Miller KD, Siegel RL, Lin CC et al (2016) Cancer treatment and survivorship statistics, 2016. CA Cancer J Clin 66:271–289. https://doi.org/10.3322/caac.21349
Millimouno FM, Dong J, Yang L et al (2014) Targeting apoptosis pathways in cancer and perspectives with natural compounds from mother nature. Cancer Prev Res (Phila) 7:1081–1107. https://doi.org/10.1158/1940-6207.CAPR-14-0136
Mirossay L, Varinská L, Mojžiš J (2018) Antiangiogenic effect of flavonoids and chalcones: an update. Int J Mol Sci 19. https://doi.org/10.3390/ijms19010027
Mitsiogianni M, Koutsidis G, Mavroudis N et al (2019) The role of isothiocyanates as cancer anti-melanoma agents. Antioxidants 8:1–35
Mukhtar E, Adhami VM, Mukhtar H (2014) Targeting microtubules by natural agents for cancer therapy. Am Assoc Cancer Res 13:275–285. https://doi.org/10.1158/1535-7163.MCT-13-0791
Ng CY, Yen H, Hsiao H, Su S (2018) Phytochemicals in skin cancer prevention and treatment : an updated review. Int J Mol Sci 19:941. https://doi.org/10.3390/ijms19040941
Nishida N, Yano H, Nishida T et al (2006) Angiogenesis in cancer. Vasc Health Risk Manag 2:213–219. https://doi.org/10.2147/vhrm.2006.2.3.213
Nishino H, Tokuda H, Satomi Y et al (2004) Cancer prevention by antioxidants. Biofactors 22:57–61
Njuguna DK, Mbuthia K, Mutuku C et al (2018) Phytochemical composition and in vitro anti-proliferative activity of Oxygonum sinuatum (Meisn.) dammer on selected cancerous cells. J Compl Altern Med Res 6:1–9. https://doi.org/10.9734/JOCAMR/2018/44413
Nouroz F, Bibi F, Noreen S, Masood N (2016) Natural killer cells enhance the immune surveillance of cancer. Egypt J Med Hum Genet 17:149–154. https://doi.org/10.1016/J.EJMHG.2015.08.006
Oh E-S, Seiki M, Gotte M, Chung J (2012) Cell adhesion in cancer. Int J Cell Biol 2012:1. https://doi.org/10.1155/2012/965618
Osborne C, Wilson P, Tripathy D (2004) Oncogenes and tumor suppressor genes in breast cancer: potential diagnostic and therapeutic applications. Oncologist 9:361–377
Pavese JM, Farmer RL, Bergan RC (2010) Inhibition of cancer cell invasion and metastasis by genistein. Cancer Metastasis Rev 29:465–482. https://doi.org/10.1007/s10555-010-9238-z
Prasad R, Katiyar SK (2015) Polyphenols from green tea inhibit the growth of melanoma cells through inhibition of class I histone deacetylases and induction of DNA damage. Gene Cancer 6:49–61
Purnamasari R, Winarni D, Permanasari AA et al (2019) Anticancer activity of methanol extract of Ficus carica leaves and fruits against proliferation, apoptosis, and necrosis in Huh7it cells. Cancer Inform 18:1–7. https://doi.org/10.1177/1176935119842576
Radhakrishna Pillai G, Srivastava AS, Hassanein TI et al (2004) Induction of apoptosis in human lung cancer cells by curcumin. Cancer Lett 208:163–170. https://doi.org/10.1016/J.CANLET.2004.01.008
Rahmani AH, Al ZMA, Aly SM, Khan MA (2014) Curcumin : a potential candidate in prevention of cancer via modulation of molecular pathways. Biomed Res Int 2014:1–16
Rajasekar J, Perumal MK, Vallikannan B (2019) A critical review on anti-angiogenic property of phytochemicals. J Nutr Biochem 71:1–15. https://doi.org/10.1016/j.jnutbio.2019.04.006
Rastogi N, Mishra DP (2012) Therapeutic targeting of cancer cell cycle using proteasome inhibitors. Cell Div 7:26. https://doi.org/10.1186/1747-1028-7-26
Samarghandian S, Borji A, Farahmand SK, et al (2013) Crocus sativus L. (saffron) stigma aqueous extract induces apoptosis in alveolar human lung cancer cells through caspase-dependent pathways activation. Biomed Res Int 2013:417928. doi: https://doi.org/10.1155/2013/417928
Schnekenburger M, Karius T, Diederich M (2014) Regulation of epigenetic traits of the glutathione S-transferase P1 gene: from detoxification toward cancer prevention and diagnosis. Front Pharmacol 5:170. https://doi.org/10.3389/fphar.2014.00170
Seo E-J, Fischer N, Efferth T (2017) Role of TCTP for cellular differentiation and cancer therapy. In: Results and problems in cell differentiation. Springer, Cham, pp 263–281
Shahat AA, Hidayathulla S, Khan AA et al (2019) Phytochemical profiling, antioxidant and anticancer activities of Gastrocotyle hispida growing in Saudi Arabia. Acta Trop 191:243–247. https://doi.org/10.1016/j.actatropica.2019.01.013
Soldati L, Di Renzo L, Jirillo E et al (2018) The influence of diet on anti-cancer immune responsiveness. J Transl Med 16:75. https://doi.org/10.1186/s12967-018-1448-0
Srikanth S, Chen Z (2016) Plant protease inhibitors in therapeutics-focus on cancer therapy. Front Pharmacol 7(19). https://doi.org/10.3389/fphar.2016.00470
Suvarna V, Murahari M, Khan T et al (2017) Phytochemicals and PI3K inhibitors in cancer—an insight. Front Pharmacol 8:23. https://doi.org/10.3389/fphar.2017.00916
Tabolacci C, Forni C, Jadeja RN, Facchiano F (2019) Natural compounds against cancer, inflammation, and oxidative stress. Biomed Res Int 2019:1–2
Takooree H, Aumeeruddy MZ, Rengasamy KRR et al (2019) A systematic review on black pepper (Piper nigrum L.): from folk uses to pharmacological applications. Crit Rev Food Sci Nutr 59:1–34. https://doi.org/10.1080/10408398.2019.1565489
Thomas R, Butler E, Macchi F, Williams M (2015) Phytochemicals in cancer prevention and management? Br J Med Pract 8:a815
Thyagarajan A, Sahu RP (2018) Potential contributions of antioxidants to cancer therapy: immunomodulation and radiosensitization. Integr Cancer Ther 17:210–216. https://doi.org/10.1177/1534735416681639
Vinay DS, Ryan EP, Pawelec G et al (2015) Immune evasion in cancer: mechanistic basis and therapeutic strategies. Semin Cancer Biol 35:S185–S198. https://doi.org/10.1016/J.SEMCANCER.2015.03.004
Wallisellen HD (2019) Chemotherapy-induced hair loss. Ski Ther Lett 15:1–6
Wang H, Khor TO, Shu L et al (2012) Plants against cancer: a review on natural phytochemicals in preventing and treating cancers and their druggability. Anti Cancer Agents Med Chem 12:1281–1305
Wang H-C, Chu Y-L, Hsieh S-C, Sheen L-Y (2017) Diallyl trisulfide inhibits cell migration and invasion of human melanoma a375 cells via inhibiting integrin/facal adhesion kinase pathway. Environ Toxicol 32:2352–2359. https://doi.org/10.1002/tox.22445
Weng C-J, Yen G-C (2012) Chemopreventive effects of dietary phytochemicals against cancer invasion and metastasis: phenolic acids, monophenol, polyphenol, and their derivatives. Cancer Treat Rev 38:76–87. https://doi.org/10.1016/J.CTRV.2011.03.001
Weng J-R, Bai L-Y, Chiu C-F et al (2013) Cucurbitane triterpenoid from Momordica charantia induces apoptosis and autophagy in breast cancer cells, in part, through peroxisome proliferator-activated receptor γ activation. Evid-Based Compl Altern Med 2013:1–12. https://doi.org/10.1155/2013/935675
Wong RSY (2011) Apoptosis in cancer: from pathogenesis to treatment. J Exp Clin Cancer Res 30:87. https://doi.org/10.1186/1756-9966-30-87
Yan M, Liu Q (2016) Differentiation therapy: a promising strategy for cancer treatment 35:3. https://doi.org/10.1186/s40880-015-0059-x
Yang Z, Garcia A, Xu S et al (2013) Withania somnifera root extract inhibits mammary cancer metastasis and epithelial to mesenchymal transition. PLoS One 8:e75069. https://doi.org/10.1371/journal.pone.0075069
Yin S-Y, Yang N-S, Lin T-J (2017) Phytochemicals approach for developing cancer immunotherapeutics. Front Pharmacol 8:386. https://doi.org/10.3389/fphar.2017.00386
Younas M, Hano C, Giglioli-Guivarc’h N, Abbasi BH (2018) Mechanistic evaluation of phytochemicals in breast cancer remedy: current understanding and future perspectives. RSC Adv 8:29714–29744. https://doi.org/10.1039/C8RA04879G
Zhao H, Liu T, Mao X et al (2015) Fructus phyllanthi tannin fraction induces apoptosis and inhibits migration and invasion of human lung squamous carcinoma cells in vitro via MAPK/MMP pathways. Acta Pharmacol Sin 36:758–768. https://doi.org/10.1038/aps.2014.130
Zorofchian Moghadamtousi S, Karimian H, Rouhollahi E et al (2014) Annona muricata leaves induce G1 cell cycle arrest and apoptosis through mitochondria-mediated pathway in human HCT-116 and HT-29 colon cancer cells. J Ethnopharmacol 156:277–289. https://doi.org/10.1016/j.jep.2014.08.011
Acknowledgments
Authors are very thankful to Dr. Neetin S. Desai, Amity Institute of Biotechnology, for providing necessary guidance and support. Authors also thank Dr. Laxmikant H. Kamble, School of Life Sciences, S.R.T.M. University, Nanded, for the editorial assistance.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Wagh, N.S., Pai, S.R., Sonkamble, V.V. (2020). Phytochemicals in the Prevention and Cure of Cancers. In: Swamy, M. (eds) Plant-derived Bioactives. Springer, Singapore. https://doi.org/10.1007/978-981-15-2361-8_16
Download citation
DOI: https://doi.org/10.1007/978-981-15-2361-8_16
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-15-2360-1
Online ISBN: 978-981-15-2361-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)